1. Home
  2. DCGO vs CLNN Comparison

DCGO vs CLNN Comparison

Compare DCGO & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DocGo Inc.

DCGO

DocGo Inc.

HOLD

Current Price

$0.36

Market Cap

63.5M

Sector

Health Care

ML Signal

HOLD

Logo Clene Inc.

CLNN

Clene Inc.

HOLD

Current Price

$4.55

Market Cap

57.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DCGO
CLNN
Founded
2015
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Managed Health Care
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
63.5M
57.4M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
DCGO
CLNN
Price
$0.36
$4.55
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
4
Target Price
$2.38
$33.75
AVG Volume (30 Days)
707.5K
129.2K
Earning Date
05-11-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$322,196,000.00
$200,000.00
Revenue This Year
N/A
$17.64
Revenue Next Year
$6.77
$19,516.77
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.35
$3.25
52 Week High
$1.65
$13.50

Technical Indicators

Market Signals
Indicator
DCGO
CLNN
Relative Strength Index (RSI) 35.11 56.15
Support Level $0.35 $4.53
Resistance Level $0.69 $4.70
Average True Range (ATR) 0.03 0.39
MACD 0.01 0.12
Stochastic Oscillator 19.58 88.97

Price Performance

Historical Comparison
DCGO
CLNN

About DCGO DocGo Inc.

DocGo Inc is a provider of last-mile mobile health services and integrated medical mobility solutions. The company uses its care delivery platform to provide mobile health services, virtual care management, and ambulance services. It has two reporting segments: Mobile Health Services and Transportation Services. A majority of its revenue is generated from the Mobile Health Services segment, which includes various healthcare services performed at homes, offices, and other locations and event services such as on-site healthcare support at sporting events and concerts. Geographically, the company generates a majority of its revenue from the United States and the rest from the United Kingdom.

About CLNN Clene Inc.

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.

Share on Social Networks: